According to recent filings covering the 90 days ending February 07, 2026, the three most significant insider holders at Sunshine Biopharma are Cfo/Secretary Camille Sebaaly (4 shares), Chief Executive Officer Steve N. Slilaty (3 shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Camille Sebaaly | Cfo/Secretary | 4 | 01 Dec, 2022 |
| Steve N. Slilaty | Chief Executive Officer | 3 | 05 Mar, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Mar, 2024 | Steve N. Slilaty | Series B Preferred Stock | A | 100,000 | $0.10 | 3 | D | P |
| 08 Feb, 2024 | Steve N. Slilaty | Series B Preferred Stock | A | 20,000 | $0.10 | 1 | D | P |
| 30 Nov, 2022 | Camille Sebaaly | - | - | 4 | D | |||
| 30 Nov, 2022 | Camille Sebaaly | Common Stock | A | 30,000 | $0.76 | 4 | D | P |
| 03 Jun, 2022 | Camille Sebaaly | Common Stock | A | 25,000 | $1.22 | 4 | D | P |
| 18 Feb, 2022 | Steve N. Slilaty | - | - | 0 | D | |||
| 18 Feb, 2022 | Steve N. Slilaty | Series B Preferred Stock | D | 990,000 | $0.10 | 0 | D | D |
| 06 Jan, 2021 | Steve N. Slilaty | Common Stock | A | 20,000,000 | $0.00 | 0 | D | A |
| 06 Jan, 2021 | Camille Sebaaly | - | - | 0 | D | |||
| 06 Jan, 2021 | Camille Sebaaly | Common Stock | A | 20,000,000 | $0.00 | 0 | D | A |
| 06 Jan, 2021 | Abderrazzak Merzouki | Common Stock | A | 20,000,000 | $0.00 | 0 | D | A |
| 17 Jun, 2020 | Steve N. Slilaty | Series "B" Preferred Stock | A | 500,000 | $0.10 | 0 | D | A |
| 11 Sep, 2019 | Camille Sebaaly | Common Stock | A | 11,000,000 | $0.00 | 0 | D | A |
| 02 Sep, 2019 | Steve N. Slilaty | Common Stock | A | 13,000,000 | $0.00 | 0 | D | A |
| 02 Sep, 2019 | Camille Sebaaly | Common Stock | A | 13,000,000 | $0.00 | 0 | D | A |
| 27 Aug, 2018 | Steve N. Slilaty | Common Stock | A | 38,000,000 | $0.00 | 0 | D | A |
| 27 Aug, 2018 | Camille Sebaaly | Common Stock | A | 38,000,000 | $0.00 | 0 | D | A |
| 27 Aug, 2018 | Abderrazzak Merzouki | Common Stock | A | 38,000,000 | $0.00 | 0 | D | A |
| 20 Jun, 2018 | Steve N. Slilaty | Common Stock | A | 27,000,000 | $0.00 | 0 | D | A |
| 20 Jun, 2018 | Camille Sebaaly | Common Stock | A | 27,000,000 | $0.00 | 0 | D | A |